176 related articles for article (PubMed ID: 38665263)
1. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
[TBL] [Abstract][Full Text] [Related]
2. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
3. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
4. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
[TBL] [Abstract][Full Text] [Related]
5. Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine.
Cellini M; Santaguida MG; Gatto I; Virili C; Del Duca SC; Brusca N; Capriello S; Gargano L; Centanni M
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1454-8. PubMed ID: 24796930
[TBL] [Abstract][Full Text] [Related]
6. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
7. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
8. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
9. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
Vita R; Saraceno G; Trimarchi F; Benvenga S
Endocrine; 2013 Feb; 43(1):154-60. PubMed ID: 22932947
[TBL] [Abstract][Full Text] [Related]
10. The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.
Ruchała M; Szczepanek-Parulska E; Zybek A
Endokrynol Pol; 2012; 63(4):318-23. PubMed ID: 22933169
[TBL] [Abstract][Full Text] [Related]
11. Decrease in TSH levels after lactose restriction in Hashimoto's thyroiditis patients with lactose intolerance.
Asik M; Gunes F; Binnetoglu E; Eroglu M; Bozkurt N; Sen H; Akbal E; Bakar C; Beyazit Y; Ukinc K
Endocrine; 2014 Jun; 46(2):279-84. PubMed ID: 24078411
[TBL] [Abstract][Full Text] [Related]
12. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
13. Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine.
Fallahi P; Ferrari SM; Marchi S; De Bortoli N; Ruffilli I; Antonelli A
Endocrine; 2017 Jul; 57(1):175-178. PubMed ID: 27577569
[No Abstract] [Full Text] [Related]
14. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
15. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
16. Identification of Resistance to Exogenous Thyroxine in Humans.
Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
[No Abstract] [Full Text] [Related]
17. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis.
Jubiz W; Ramirez M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1031-4. PubMed ID: 24601693
[TBL] [Abstract][Full Text] [Related]
18. Lactose intolerance revealed by severe resistance to treatment with levothyroxine.
Muñoz-Torres M; Varsavsky M; Alonso G
Thyroid; 2006 Nov; 16(11):1171-3. PubMed ID: 17123345
[TBL] [Abstract][Full Text] [Related]
19. The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.
Yavuz S; Linderman JD; Smith S; Zhao X; Pucino F; Celi FS
J Clin Endocrinol Metab; 2013 May; 98(5):E862-6. PubMed ID: 23585666
[TBL] [Abstract][Full Text] [Related]
20. [Pseudomalabsorption of levothyroxine: a case report].
Pedrosa W; Santana G
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):308-13. PubMed ID: 16184262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
